SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156,211 | -14.1% | 5,666 | -6.4% | 0.00% | – |
| Q2 2023 | $181,892 | -19.9% | 6,051 | -3.5% | 0.00% | – |
| Q1 2023 | $227,126 | +19.1% | 6,269 | +17.3% | 0.00% | – |
| Q4 2022 | $190,692 | -3.7% | 5,346 | -8.8% | 0.00% | – |
| Q3 2022 | $198,000 | +2.1% | 5,859 | -12.5% | 0.00% | – |
| Q2 2022 | $194,000 | -37.2% | 6,694 | -30.1% | 0.00% | -100.0% |
| Q1 2022 | $309,000 | -16.3% | 9,573 | -24.3% | 0.00% | 0.0% |
| Q4 2021 | $369,000 | +7.3% | 12,650 | -2.1% | 0.00% | 0.0% |
| Q3 2021 | $344,000 | -18.3% | 12,916 | -5.6% | 0.00% | 0.0% |
| Q2 2021 | $421,000 | +23.1% | 13,685 | +4.7% | 0.00% | 0.0% |
| Q1 2021 | $342,000 | +20.4% | 13,066 | +15.8% | 0.00% | 0.0% |
| Q4 2020 | $284,000 | +5.6% | 11,282 | -12.9% | 0.00% | 0.0% |
| Q3 2020 | $269,000 | -32.6% | 12,946 | -22.8% | 0.00% | 0.0% |
| Q2 2020 | $399,000 | +9.3% | 16,768 | -17.3% | 0.00% | 0.0% |
| Q1 2020 | $365,000 | -26.0% | 20,269 | -2.5% | 0.00% | 0.0% |
| Q4 2019 | $493,000 | -32.7% | 20,796 | -21.8% | 0.00% | -50.0% |
| Q3 2019 | $732,000 | -31.4% | 26,598 | -17.5% | 0.00% | -33.3% |
| Q2 2019 | $1,067,000 | -24.4% | 32,236 | -19.9% | 0.00% | -25.0% |
| Q1 2019 | $1,411,000 | +18.1% | 40,254 | +11.9% | 0.00% | 0.0% |
| Q4 2018 | $1,195,000 | -17.4% | 35,986 | +25.3% | 0.00% | 0.0% |
| Q3 2018 | $1,446,000 | +1.3% | 28,719 | +20.3% | 0.00% | 0.0% |
| Q2 2018 | $1,428,000 | +25.7% | 23,873 | -3.7% | 0.00% | +33.3% |
| Q1 2018 | $1,136,000 | +2.9% | 24,790 | -10.5% | 0.00% | 0.0% |
| Q4 2017 | $1,104,000 | -14.0% | 27,692 | -13.7% | 0.00% | -25.0% |
| Q3 2017 | $1,284,000 | -21.7% | 32,083 | -15.6% | 0.00% | -20.0% |
| Q2 2017 | $1,639,000 | +27.6% | 38,022 | -7.2% | 0.01% | +25.0% |
| Q1 2017 | $1,284,000 | +1.5% | 40,990 | -18.2% | 0.00% | -20.0% |
| Q4 2016 | $1,265,000 | -6.3% | 50,098 | -8.1% | 0.01% | 0.0% |
| Q3 2016 | $1,350,000 | +10.8% | 54,508 | -8.9% | 0.01% | 0.0% |
| Q2 2016 | $1,218,000 | +36.4% | 59,804 | +2.1% | 0.01% | +25.0% |
| Q1 2016 | $893,000 | -0.1% | 58,599 | -12.0% | 0.00% | 0.0% |
| Q4 2015 | $894,000 | +98.2% | 66,584 | +106.9% | 0.00% | +100.0% |
| Q3 2015 | $451,000 | +615.9% | 32,179 | +760.9% | 0.00% | – |
| Q2 2015 | $63,000 | -55.6% | 3,738 | -68.2% | 0.00% | -100.0% |
| Q1 2015 | $142,000 | +44.9% | 11,765 | 0.0% | 0.00% | – |
| Q4 2014 | $98,000 | +2.1% | 11,765 | +6.5% | 0.00% | – |
| Q3 2014 | $96,000 | -20.7% | 11,050 | 0.0% | 0.00% | – |
| Q2 2014 | $121,000 | +22.2% | 11,050 | 0.0% | 0.00% | – |
| Q1 2014 | $99,000 | +19.3% | 11,050 | 0.0% | 0.00% | – |
| Q4 2013 | $83,000 | +2.5% | 11,050 | 0.0% | 0.00% | – |
| Q3 2013 | $81,000 | – | 11,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |